ImpriMed
A precision-oncology service that tests live cancer cells against drugs and uses clinical data to predict which treatments may work best for each patient.
$10MSeries A2 bridge
ParticipantND
NAVER D2SF
Activity from announced rounds
All recorded activity
- Rounds participated in
- 10
- Confirmed lead rounds
- 0 8 roles undisclosed
- New companies
- 10 First participation on record · 0 follow-on
- Funding in participating rounds
- $25.6M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
1 more
Media & gaming1
By country
Rounds
10 in all activityF4GE
Standardizes Korean factory data to connect manufacturers with global defense and industrial buyers
UndisclosedSeed
Role not disclosedNdotLight
Generates simulation-ready 3D data for physical AI training
₩15BSeries B
Role not disclosedSAZO
Cross-border shopping infrastructure connecting commerce platforms with payments, logistics and customs processes.
UndisclosedStrategic
Role not disclosedSoundable Health
Develops AI-powered acoustic analysis for clinical-grade diagnostics through everyday devices
UndisclosedUndisclosed
Role not disclosedNuvilab
Develops AI-powered nutrition analytics solution for healthcare
UndisclosedUndisclosed
Role not disclosedAnyware Robotics
Anyware Robotics builds mobile robots and control software for physically demanding material-handling work in warehouses and industrial facilities.
UndisclosedInvestment
ParticipantKhameleon
Develops robots for housekeeping tasks in hotels
UndisclosedPre-Seed
Role not disclosedCNAPS.AI
Develops AI workflow automation platform connecting multiple AI models
UndisclosedSeed
Role not disclosedCashmere
Connects premium content publishers with AI companies, providing data infrastructure for licensin...
$5MSeed
Role not disclosed